RxDoctor Payments Data

James Ellison, MD

Geriatric Psychiatry · Osterville, MANPI 1144226630

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $979 of the $1,160 with a category attached, or 84.4%. Biogen accounts for 85.2% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2020 at $989 and has fallen 98.0% since, to $19 in 2025.

$1,160in general payments, 2019–2025

Across 9 payments — averaging $128.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$989
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$50
  • Boehringer Ingelheim$41
  • Lundbeck LLC$21
  • Axsome Therapeutics, Inc.$20
  • Otsuka America Pharmaceutical, Inc.$20
  • plus $19 from 1 others
$32,124in research payments, 2019–2025

Across 9 payments — averaging $3569.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Genentech, Inc.$14K
  • Avanir Pharmaceuticals, Inc.$12K
  • Eli Lilly$4K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$2K

What the payments were for

  • Consulting fees$97984%
  • Food & beverage$17215%
  • Education$101%

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,160 in reported general payments places this provider in the 65th percentile of 23 geriatric psychiatry providers in Massachusetts.

See all geriatric psychiatry providers in Massachusetts

Medicare billing

Part B allowed, 2024
$78,612
Medicare patients
205
Services billed
654

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrintellixVortioxetine Hydrobromide13$12,136
Aripiprazole66$7,864
Vilazodone Hcl15$4,537
Duloxetine Hcl81$3,899
Bupropion XlBupropion Hcl19$2,729
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine22$2,514
Mirtazapine64$2,256
Memantine Hcl59$2,236
Escitalopram Oxalate121$2,204
Methylphenidate ErMethylphenidate Hcl18$1,828
Buspirone Hcl30$1,619
Divalproex Sodium ErDivalproex Sodium13$1,087
Bupropion Hcl SrBupropion Hcl41$1,079
Gabapentin41$857
Quetiapine Fumarate41$796

Paid to pharmacies, not to this prescriber.

Other geriatric psychiatry in Osterville

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →